Nominations now open for the 2020 Canadian Blood Services Lifetime Achievement Award

Recipients of the Canadian Blood Services Lifetime Achievement Award are individuals whose landmark contributions are recognized as both extraordinary and world class in the field of transfusion or transplantation medicine, stem cell or cord blood research in Canada and/or abroad.

Who can be nominated?

To be nominated for the Canadian Blood Services Lifetime Achievement Award, an individual must have contributed significantly to improving the safety and/or quality of blood, blood products, stem cells and/or cord blood or has made noteworthy improvements or advances in transfusion or transplantation medicine practice. Their record of publication should be of significance and their professional reputation should be aligned with the goals and reputation of Canadian Blood Services, reflecting a quality culture driven by excellence.

Be inspired by past recipients

Typically, there is only one recipient of the Canadian Blood Services Lifetime Achievement Award each year, but in 2019 two outstanding innovators were recognized. Dr. Donna Wall was honoured for her medical career spanning almost 40 years during which she made significant contributions to the evolution of blood and marrow transplantation across North America. Transplant physician and scientist Dr. Harold Atkins was honoured for his career dedicated to discovering innovative methods for stem cell transplantation.

The 2020 Lifetime Achievement Award will be presented on September 21, 2020 in Ottawa at the annual national Honouring Canada’s Lifeline event where Canadian Blood Services honours donors, volunteers, peer recruiters and partners for their outstanding dedication and achievements.

To learn about past recipients of the Canadian Blood Services Lifetime Achievement Award, and other awardees at the Honouring Canada's Lifeline annual ceremony, click here.

Nomination requirements

• Provide a short introduction and summary in 150 words or less of the nominee’s contribution to improving the safety and/or quality of blood, blood products or stem cells, or contribution to advances in transfusion medicine practice
• Present a brief biography including academic, research, clinical and administrative positions, awards or recognitions
• Outline how the work of the nominee is set apart from the work of others in the field
• Provide a nominee’s full current curriculum vitae and contact information for the nominee including full name, mailing address, telephone number(s) and email address
• Provide name and contact information for the nominator(s)

Candidates should be unaware that they have been nominated for this award.

Process for nominations

To nominate an individual for the Canadian Blood Services Lifetime Achievement Award, please submit in writing to:

Canadian Blood Services Lifetime Achievement Award Nominating Committee
c/o Dr. Isra Levy, Vice President, Medical Affairs and Innovation
Canadian Blood Services
1800 Alta Vista Drive
Ottawa, Ontario K1G 4J5
isra.levy@blood.ca

Nominations must be received by May 19, 2020.

More information

The Canadian Blood Services Lifetime Achievement Award came into existence in 2002. To date, the Canadian Blood Services Board of Directors has selected the following individuals for this prestigious award:

• Dr. John Bowman, 2002
• Ms. Marie Cutbush Crookston, 2002
• Dr. Morris A. Blajchman, 2003
• Dr. Peter Pinkerton, 2004
• Dr. John Freedman, 2006
• Dr. Hans Messner, 2007
• Mr. Justice Horace Krever, 2008
• Dr. Gail Rock, 2009
• Dr. Victor Blanchette, 2010
• Dr. Allen Eaves and Dr. Connie Eaves, 2011
• Dr. Celso Bianco, 2012
• The Canadian Hemophilia Society, 2013
• Dr. John Dossetor, 2013
• Dr. Gershon Growe, 2014
• Dr. Bruce McManus, 2015
• Dr. David Lillicrap, 2016
• Nancy Heddle, Leah Hollins 2017
• André Picard, 2018
• Dr. Harold Atkins and Dr. Donna Wall, 2019

Canadian Blood Services – Driving world-class innovation

Through discovery, development and applied research, Canadian Blood Services drives world-class innovation in blood transfusion, cellular therapy and transplantation—bringing clarity and insight to an increasingly complex healthcare future. Our dedicated research team and extended network of partners engage in exploratory and applied research to create new knowledge, inform and enhance best practices, contribute to the development of new services and technologies, and build capacity through training and collaboration. Find out more about our research impact. 

The opinions reflected in this post are those of the author and do not necessarily reflect the opinions of Canadian Blood Services nor do they reflect the views of Health Canada or any other funding agency.